Clinical and epidemiological characteristics of severe acute respiratory infection due to respiratory syncytial virus in children under 5 years
DOI:
https://doi.org/10.24265/horizmed.2016.v16n3.02Keywords:
Respiratory syncytial virus, Respiratory tract infection, EpidemiologyAbstract
Objective: To compare the clinical and epidemiological characteristics of severe acute respiratory infection in children under 5 years old with and without infection due to respiratory syncytial virus. Material and methods: Retrospective study in a sample of 65 cases and 65 controls in children under 5 years old with acute respiratory infection (SARI) treated at the Pediatric Emergency Hospital during 2014. The diagnosis of RSV test was performed using direct inmufluorescencia (IFD) in nasal and throat samples (D3 Ultra DFA Respiratory Virus 8 ™ Screening & ID Kit). The results were expressed in absolute and relative terms; the analysis was performed by measures of central tendency, chi-square, “t” Student and Mann Whitney tests. Results: Significant differences were found between cases and controls in the average age in the month of infection, the average respiratory rate, use of mechanical ventilation in antibiotic treatment and diagnosis of bronchiolitis at medical discharge. Conclusions: The results show that there are clinical and epidemiological differences between the cases and controls.
Downloads
References
Valdés-Ramírez O, Corzo-López M, El virus sincitial respiratorio humano: una panorámica. Revista CENIC. Ciencias Biológicas 2013 44. Disponible en: http://www.redalyc.org/articulo.oa?id=181227534005
Respiratory syncytial virus activity--United States, 1999-2000 season. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep. 2000;49(48):1091.
Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et. all. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588.
Spence L, Barratt N. Respiratory syncytial virus associated with acute respiratory infections in Trinidadian patients. Am J Epidemiol. 1968;88(2):257.
Staat MA, Henrickson K, Elhefni H, Groothuis J, Makari D. Prevalence of respiratory syncytial virus-associated lower respiratory infection and apnea in infants presenting to the emergency department. Pediatr Infect Dis J. 2013;32(8):911.
American Academy of Pediatrics. Respiratory syncytial virus. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.609.
Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282(15):1440.
Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J. 2012;31(1):5.
Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et all. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010; 375(9725):1545.
Instituto Nacional de Salud. Informe de la vigilancia de influenza y otros virus respiratorios basada en laboratorio. Lima-Perú: 2015.
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et. all. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec;380(9859):2095-128.
Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140(6):543.
Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis. 2001;33(6):792.
Openshaw PJ, Culley FJ, Olszewska W. Immunopathogenesis of vaccine-enhanced RSV disease.Vaccine.2001;20(1): 27-31.
Weisman LE;. Respiratory syncytial virus prevention and treatment: past,present, and future. CardiovascHematol Agents. Med Chem. 2009;7:223-33.
Shadman KA, Wald ER. A review of palivizumab and emerging therapies for respiratory syncytial virus. Expert Opin Biol Ther. 2011;11(11):1455-67.
Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson DW, Plint AC, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2011 Jun 15;(6).
Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014 Jun 17;6.
Cade A, Brownlee KG, Conway SP, Haigh D, Short A, Brown J, et al. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child. 2000 Feb; 82(2): 126–130.
Van Woensel JB, Vyas H, STAR Trial Group. Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial. Crit Care Med. 2011 Jul;39(7):1779-83.
Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2004;(3).
Lozano JM. Bronchiolitis. Clin Evid. 2004; Department of Paediatrics and Clinical Epidemiology Unit, School of Medicine, Universidad Javeriana, BogotáDC, Colombia.
King VJ, Viswanathan M, Bordley WC, Jackman AM, Sutton SF, Lohr KN, Carey TS. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med. 2004 Feb; 158(2):127-37.
Spurling G, Doust J, Del Mar C. Eriksson L Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev. 2011 Jun 15;(6):CD005189.
Collard M, Moreno L, Bujedo E, Marquez I, Mosca L, Ferreira P, et all. Prescripción de antibióticos en lactantes hospitalizados con neumonía por virus Sincitial respiratorio. Arch Argent Pediatr 2008; 106(6):515-517.
Farley R, Spurling GKP, Eriksson L, Del Mar CB. Antibiotics for bronchiolitis in children under two years of age. Cochrane Database of Systematic Reviews 2014, Issue 10. Art. No.: CD005189.
Directiva Sanitaria para la Vigilancia Epidemiológica de Influenza, de Otros Virus Respiratorios (OVR) e Infecciones Respiratorias Agudas Graves (IRAG) en el Perú. MINSA–DGE v01 2012.
Directiva Sanitaria para la Vigilancia de lãs Infecciones Respiratorias Agudas MINSA-DGE v01 2014.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
